UC San Francisco is the leading university exclusively focused on health. @UCSF on Instagram, Facebook, LinkedIn and YouTube
UCSF
Loading...
The celebration continues. 🎓 Explore graduation ceremonies across UCSF and hear from graduates reflecting on their time here and what's next. https://ow.ly/ZC5P50Z9egA
Congratulations to the 2026 Chancellor’s Distinguished Service Award recipients. Across UCSF, these faculty and staff members are supporting our communities, patients, and learners through service, leadership, and care. Meet this year’s honorees: https://tiny.ucsf.edu/ds7tkp
UCSF researchers are busy developing cutting-edge therapies for cancer, diabetes, dementia, and more, all thanks to NIH funding support. The university is the largest public recipient of NIH funds again in 2026. https://ow.ly/CCIX50YZ7i3
When chronic lung disease patients struggle to get optimal care, symptoms can quickly worsen. A new UCSF School of Medicine study found that health coaching led to better breathing, milder symptoms, and 60% more recommended care. www.ucsf.edu/news/2026/05...
People with #Epilepsy experience more than seizures. UCSF researchers discovered how momentary “brain blips” — that happen thousands of times a day and disrupt memory, attention, and language — might be prevented. https://ow.ly/fvqt50YZ7BH
GLP-1 medications have been very effective for weight loss. Scientists are now exploring whether they may also impact brain health. UCSF scientists have found evidence that GLP-1s may help lower the risk of dementia and reduce addiction cravings. https://ow.ly/hRI250YZ7sK
Generic drugs saved people trillions. Could biosimilars do the same? Biologics like Ozempic make up 5% of prescriptions but more than half of drug spending. A new study found different approval rules may be slowing access to lower-cost alternatives. https://ow.ly/215150Z9ekH
1 in 5 teens has had a major depressive episode — an 80% increase in a decade. UCSF scientists are exploring how probiotics might help treat depression. Studies show the gut sends signals which can affect mood, stress, and well-being. https://ow.ly/oZXo50YYqfa
UCSF has received a $100 million gift from longtime supporters Kathy Chiao and Kenneth Hao. This major investment will help modernize our hospitals and advance cancer research through the Weill Cancer Hub West. tiny.ucsf.edu/huNubD
Big news from UCSF! Mark Anderson, MD, PhD, director of the UCSF Diabetes Center, has been elected to the National Academy of Sciences, one of the highest honors in American science. A true pioneer in diabetes and autoimmune research. Congrats! https://ow.ly/Rocv50Z6t7v
UCSF received $824 million from the National Institutes of Health (NIH) in 2025 to drive the discovery, translational, and clinical science that leads to new treatments for disease and advances U.S. leadership in health and science.
Epilepsy physicians Jon Kleen and Eddie Chang used high-resolution technology to see how cognition is disrupted in people with epilepsy and predict when it will occur. The new view points the way to being able to fend of these disruptions.
ow.ly
Multiple clinical trials have shown that GLP-1s are safe and effective for patients with obesity, diabetes and cardiovascular conditions. New evidence shows that the drugs may also protect against neurological diseases, like dementia, Parkinson's, and substance use disorder.
ow.ly
UCSF research shows that international rules for biosimilars, mimics of biologic drugs like Ozempic and insulin, need to improve and match each another to encourage biosimilar development, testing, and approval. This would dramatically improve drug affordability just like generics has done.
UCSF's Cherry Leung, associate professor of community health systems with the UC San Francisco School of Nursing, researches the gut-brain axis as a potential adjunct therapy for improving adolescent mental health.
UCSF has received a $100 million commitment from longtime supporters Kathy Chiao and Kenneth Hao to address its most urgent capital needs and accelerate innovation to advance human health.
Mark Anderson, MD, PhD, a pioneer in diabetes research and professor of medicine at UCSF, has been elected to the National Academy of Sciences — one of the highest honors in American science.
